Reading the tape
NASDAQ: MDLN
Medline Inc.
Healthcare · Medical - Instruments & Supplies
Market Cap
$35.72B
52w High
$50.88
52w Low
$34.89
P/E
30.88
Volume
980.68K
Outstanding Shares
811.65M
Price vs Fundamentals
Why The Stock Is Moving
Mixed / unclearLow confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: 6.73%Revenue (YoY): 11.47%FCF (YoY): 24.13%
What changed
The stock rose 6.73% over the last year. Revenue grew 11.47% year over year. Operating margin moved from 8.72% to 7.78%. Free cash flow grew 24.13% year over year.
What the market seems to be pricing
The stock has moved higher against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 7.78%. A decisive move in revenue — currently up 11.47% — would be the clearest signal to resolve the ambiguity.
Company profile
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally.
CEOJames Boyle
SectorHealthcare
IndustryMedical - Instruments & Supplies
Employees43,000
IPO dateDec 17, 2025
Valuation
Forward P/E—
EV/EBITDA15.34
Enterprise value$44.73B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth21.9%
Gross margin24.58%▲7.21%vs FY2024
Operating margin7.8%▼10.81%vs FY2024
ROE10.79%▲48.64%vs FY2024
Analyst consensus
RatingBuy
Target price$48.82▲10.94%
9
Buy
1
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 6, 2026
Q2 FY26 · EPS est $0.29 · Revenue est $7.16B
View